Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 4 of 100
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Lila MacLellan
March 1, 2025
Health
GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
By
Ryan Hogg
February 28, 2025
Finance
Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By
Madison Muller
and
Bloomberg
February 26, 2025
Leadership
Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
By
Fortune Editors
February 26, 2025
Health
With RFK Jr. in charge, supplement makers see chance to cash in
By
KFF Health News
and
Arthur Allen
February 25, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By
Ryan Hogg
February 19, 2025
Health
Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By
Lindsey Leake
February 15, 2025
Health
Experts sound the alarm as Ohio farmworker’s bird flu sparks fear it’s the next pandemic
By
Lindsey Leake
February 13, 2025
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By
Lindsey Leake
February 11, 2025
Health
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
By
Lindsey Leake
February 7, 2025
Aging Well
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By
Lindsey Leake
February 6, 2025
Health
AstraZeneca sees profits surge despite Chinese import tax allegations
By
AFP
February 6, 2025
Commentary
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By
Jeffrey Sonnenfeld
and
Steven Tian
February 5, 2025
Health
Patients will pay more for prescription meds and face drug shortages amid Trump tariffs, pharma groups warn
By
Lindsey Leake
February 5, 2025
Most Popular
AI
Netflix will pay you up to $700K per year—and let you work fully remote—if you can harness AI to make employees more...
By
Dave Smith
Success
‘I don’t know why I need to go to college’: Ford CEO says his Gen Z son worked as a mechanic and wondered if the 4-year...
By
Nick Lichtenberg
Success
Meet Mira Murati, the 36-year-old tech prodigy who shot to fame at OpenAI and now runs a startup that's a poaching...
By
Dave Smith